These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15779446)

  • 21. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
    Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
    Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of type 2 diabetes mellitus in polycystic ovary syndrome: A review.
    Anwar S; Shikalgar N
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S913-S917. PubMed ID: 28711517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired glucose regulation and type 2 diabetes in children and adolescents.
    Kempf K; Rathmann W; Herder C
    Diabetes Metab Res Rev; 2008 Sep; 24(6):427-37. PubMed ID: 18551709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [NAVIGATOR trial (nateglinide)].
    Tsujii S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():483-7. PubMed ID: 15779426
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pathophysiological conditions progressing from impaired glucose tolerance: high blood pressure].
    Katayama S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():242-5. PubMed ID: 15779379
    [No Abstract]   [Full Text] [Related]  

  • 26. Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction.
    Spadaro L; Alagona C; Palermo F; Piro S; Calanna S; Parrinello G; Purrello F; Rabuazzo AM
    Nutr Metab Cardiovasc Dis; 2011 Mar; 21(3):206-12. PubMed ID: 20096546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.
    Cavaghan MK; Ehrmann DA; Polonsky KS
    J Clin Invest; 2000 Aug; 106(3):329-33. PubMed ID: 10930434
    [No Abstract]   [Full Text] [Related]  

  • 29. [The prevalence of impaired glucose tolerance in life-style related disease].
    Tomono S; Utsugi T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():78-81. PubMed ID: 15779349
    [No Abstract]   [Full Text] [Related]  

  • 30. Problems related to definitions and epidemiology of type 2 (non-insulin-dependent) diabetes mellitus: studies throughout the world.
    Alberti KG
    Diabetologia; 1993 Oct; 36(10):978-84. PubMed ID: 8243882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity and T2DM in youth.
    Weiss R; Caprio S
    Endocr Res; 2008; 33(1-2):59-72. PubMed ID: 19156574
    [No Abstract]   [Full Text] [Related]  

  • 32. [The internal and external cohort studies about impaired glucose tolerance].
    Shibazaki S; Nagai M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():82-6. PubMed ID: 15779350
    [No Abstract]   [Full Text] [Related]  

  • 33. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited.
    Ceriello A; Motz E
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):816-23. PubMed ID: 14976002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A primary defect in glucose production alone cannot induce glucose intolerance without defects in insulin secretion.
    Mangiafico SP; Lim SH; Neoh S; Massinet H; Joannides CN; Proietto J; Andrikopoulos S; Fam BC
    J Endocrinol; 2011 Sep; 210(3):335-47. PubMed ID: 21700659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resistance to insulin and polycystic ovary syndrome].
    Ducluzeau PH; Laville M; Vidal H; Pugeat M
    Diabetes Metab; 2001 Sep; 27(4 Pt 2):S7-12. PubMed ID: 11787441
    [No Abstract]   [Full Text] [Related]  

  • 36. [Impaired glucose tolerance in the elderly--prevalence, pathogenesis and management].
    Ito H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():341-4. PubMed ID: 15779400
    [No Abstract]   [Full Text] [Related]  

  • 37. Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?
    Giordano C; Guarnotta V; Pivonello R; Amato MC; Simeoli C; Ciresi A; Cozzolino A; Colao A
    Eur J Endocrinol; 2014 Feb; 170(2):311-9. PubMed ID: 24255133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes and pancreatic cancer.
    Muniraj T; Chari ST
    Minerva Gastroenterol Dietol; 2012 Dec; 58(4):331-45. PubMed ID: 23207610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of sugar-sweetened beverage intake on the development of type 2 diabetes mellitus in subjects with impaired glucose tolerance: the Mihama diabetes prevention study.
    Teshima N; Shimo M; Miyazawa K; Konegawa S; Matsumoto A; Onishi Y; Sasaki R; Suzuki T; Yano Y; Matsumoto K; Yamada T; Gabazza EC; Takei Y; Sumida Y
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(1):14-9. PubMed ID: 25994135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Etiologies of impaired glucose tolerance and impaired fasting glycemia].
    Ohara T; Kasuga M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():89-94. PubMed ID: 15779351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.